The role of paroxetine in fatigue and depression of patients under chemotherapeutic treatment

American Journal of Therapeutics

Volumn 20, Issue 3, 2013, Pages 254-256

  Heras, Panagiotis ^a,b   Kritikos, Konstantinos ^b   Hatzopoulos, Antonios ^a,b   Kritikos, Nikolaos ^b   Heras, Vasileios ^b   Mitsibounas, Dimitrios ^b  

^a General Hospital of Nafplion   (Greece)

^b Hellenic Medical Society for the Study of Psychosomatic Problems   (Greece)

Author keywords

Chemotherapy; Depression; Fatigue; Paroxetine

Indexed keywords

ANTINEOPLASTIC AGENT; PAROXETINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FATIGUE; FATIGUE SYMPTOM CHECKLIST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL ASSESSMENT OF FATIGUE; MULTIPLE CYCLE TREATMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROFILE OF MOOD STATES; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTINEOPLASTIC AGENTS; DEPRESSION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84880078861     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e318187de2c     Document Type: Article

References (17)

1. Cassem NH. Handbook of General Hospital Psychiatry. 3rd ed. Boston, MA: Mosby; 1998:343-369.
2. Wise MG, Rundel JB. In: Hales RE, ed. Consultation Psychiatry. 2nd ed.Washington, DC: American Psychiatric Press; 1999:247-255.
3. Glaus A, Crow R, Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer. 1996;4: 82-96.
4. Morrow GR, Shelke AR, Roscoe JA, et al. Management of cancer-related fatigue. Cancer Invest. 2005;23:229-239.
5. Mock V, Atkinson A, Barsevick A, et al. NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park). 2000;14:151-161.
6. Watson T, Mock V. Exercise as an intervention for cancerrelated fatigue. Phys Ther. 2004;84:736-743.
7. Billings JA. Outpatient Management of Advanced Cancer. Philadelphia, PA: JB Lippincott Co; 1999.
8. Jean-Pierre P, Figueroa-Moseley CD, Kohli S, et al. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist. 2007;12:11-21.
9. Pugh LC. Psychophysiological Correlates of Fatigue During Childbirth [doctoral dissertation]. Baltimore, MD: University of Maryland; 1990.
10. Tack B. Dimensions and Correlates of Fatigue in Older Adults With Rheumatoid Arthritis [doctoral dissertation]. San Francisco, CA: University of California; 1991.
11. McNair DM, Lorr M, Droppelman LF. Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971.
12. Radloff LS. The CES-D scale: a self-report depressive scale for research in the general population. J Appl Psychol Meas. 1977;1:385-401.
13. O Carl Simonton, MD: Unproven methods of cancer management. CA Cancer J Clin. 2000;32:58-61.
14. Greenberg DB. Psychiatric consultation in cancer patient. Presented at: Massachusetts General Hospital, Psychosomatic Conference; 2003; Massachusetts.
15. Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003;21:4635-4641.
16. Roscoe JA, Morrow GR, Hickok JT, et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2005;89:243-249.
17. Ryan JL, Carroll JK, Ryan EP, et al. Mechanisms of cancerrelated fatigue. Oncologist. 2007;12(Suppl 1):22-34.